Timothy Riehlman is an accomplished inventor based in East Greenbush, NY (US). He has made significant contributions to the field of biotechnology, particularly in the development of microchip capillary electrophoresis assays and reagents. With a total of 4 patents to his name, Riehlman continues to push the boundaries of innovation in protein drug analysis.

Latest Patents

Riehlman's latest patents focus on Microchip Capillary Electrophoresis (MCE) assays and reagents. These innovations are designed to assess the purity and identify impurities in protein drug product samples. The methods he has developed for analyzing analytes in protein drug samples are crucial for ensuring the quality and safety of biopharmaceuticals.

Career Highlights

Timothy Riehlman is currently employed at Regeneron Pharmaceuticals, Inc., where he applies his expertise in biotechnology to advance the company's research and development efforts. His work has been instrumental in enhancing the analytical capabilities of protein drug products.

Collaborations

Riehlman collaborates with talented professionals in his field, including Gabriel Carreau and Jeffrey Schneiderheinze. These partnerships foster a creative environment that drives innovation and leads to groundbreaking advancements in biotechnology.

Conclusion

Timothy Riehlman's contributions to the field of biotechnology through his patents and work at Regeneron Pharmaceuticals, Inc. highlight his role as a key innovator in protein drug analysis. His ongoing efforts continue to shape the future of biopharmaceutical research and development.

This text is generated by artificial intelligence and may not be accurate.